Nuveen Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.76M | Buy |
143,225
+3,038
| +2% | +$122K | ﹤0.01% | 1916 |
|
|
2024
Q3 | $6.64M | Buy |
140,187
+399
| +0.3% | +$18.9K | ﹤0.01% | 1853 |
|
|
2024
Q2 | $4.17M | Buy |
139,788
+43,793
| +46% | +$1.31M | ﹤0.01% | 2039 |
|
|
2024
Q1 | $3.86M | Sell |
95,995
-40,831
| -30% | -$1.64M | ﹤0.01% | 2112 |
|
|
2023
Q4 | $3.48M | Buy |
136,826
+41,962
| +44% | +$1.07M | ﹤0.01% | 2149 |
|
|
2023
Q3 | $1.32M | Sell |
94,864
-1,006
| -1% | -$14K | ﹤0.01% | 2461 |
|
|
2023
Q2 | $2.2M | Sell |
95,870
-18,531
| -16% | -$426K | ﹤0.01% | 2291 |
|
|
2023
Q1 | $3.39M | Sell |
114,401
-9,384
| -8% | -$278K | ﹤0.01% | 2103 |
|
|
2022
Q4 | $3.09M | Sell |
123,785
-15,850
| -11% | -$396K | ﹤0.01% | 2182 |
|
|
2022
Q3 | $3.04M | Buy |
139,635
+12,851
| +10% | +$280K | ﹤0.01% | 2171 |
|
|
2022
Q2 | $2.5M | Buy |
126,784
+19,552
| +18% | +$385K | ﹤0.01% | 2326 |
|
|
2022
Q1 | $4.35M | Sell |
107,232
-3,674
| -3% | -$149K | ﹤0.01% | 2134 |
|
|
2021
Q4 | $5.83M | Sell |
110,906
-6,055
| -5% | -$318K | ﹤0.01% | 2031 |
|
|
2021
Q3 | $7.36M | Sell |
116,961
-19,920
| -15% | -$1.25M | ﹤0.01% | 1998 |
|
|
2021
Q2 | $6.64M | Buy |
136,881
+97,387
| +247% | +$4.72M | ﹤0.01% | 2098 |
|
|
2021
Q1 | $1.53M | Buy |
39,494
+661
| +2% | +$25.7K | ﹤0.01% | 2730 |
|
|
2020
Q4 | $2.41M | Buy |
+38,833
| New | +$2.41M | ﹤0.01% | 2414 |
|